Desq Long
Sign in

Company

CORCEPT THERAPEUTICS INC

CORT · CIK 0001088856

SEC FORM 4
$144,667.11

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 17,493 shares at $8.27 per share.

Reporting Person Robb Gary Charles · Officer Title Chief Business Officer · Transaction Code M

Traded Sep 17, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001193125-26-395827 · filed 2026-09-18 · View filing →

SEC FORM 4
$29,842.72

CORCEPT THERAPEUTICS INC (CORT)

Sale of 296 shares at $100.82 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001193125-26-395837 · filed 2026-09-18 · View filing →

SEC FORM 4
$749,834.64

CORCEPT THERAPEUTICS INC (CORT)

Sale of 6,800 shares at $110.2698 per share.

Reporting Person WILSON JAMES N · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393124 · filed 2026-09-16 · View filing →

SEC FORM 4
$44,334.52

CORCEPT THERAPEUTICS INC (CORT)

Sale of 400 shares at $110.8363 per share.

Reporting Person WILSON JAMES N · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393124 · filed 2026-09-16 · View filing →

SEC FORM 4
$312,770.92

CORCEPT THERAPEUTICS INC (CORT)

Sale of 2,800 shares at $111.7039 per share.

Reporting Person WILSON JAMES N · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393124 · filed 2026-09-16 · View filing →

SEC FORM 4
$29,464.60

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 2,596 shares at $11.35 per share.

Reporting Person Lyon Joseph Douglas · Officer Title See Remarks · Transaction Code M

Traded Sep 14, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393125 · filed 2026-09-16 · View filing →

SEC FORM 4
$100,398.24

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 7,404 shares at $13.56 per share.

Reporting Person Lyon Joseph Douglas · Officer Title See Remarks · Transaction Code M

Traded Sep 14, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393125 · filed 2026-09-16 · View filing →

SEC FORM 4
$885,260.53

CORCEPT THERAPEUTICS INC (CORT)

Sale of 7,812 shares at $113.3206 per share.

Reporting Person Lyon Joseph Douglas · Officer Title See Remarks · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393125 · filed 2026-09-16 · View filing →

SEC FORM 4
$249,686.46

CORCEPT THERAPEUTICS INC (CORT)

Sale of 2,188 shares at $114.1163 per share.

Reporting Person Lyon Joseph Douglas · Officer Title See Remarks · Transaction Code S

Traded Sep 14, 2026 · Disclosed Sep 16, 2026

Source: SEC Form 4 · 0001193125-26-393125 · filed 2026-09-16 · View filing →

SEC FORM 4
$8,163.36

CORCEPT THERAPEUTICS INC (CORT)

Disposition (code F) of 72 shares at $113.38 per share.

Reporting Person Lyon Joseph Douglas · Officer Title See Remarks · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382450 · filed 2026-09-03 · View filing →

SEC FORM 4
$644,042.38

CORCEPT THERAPEUTICS INC (CORT)

Sale of 5,621 shares at $114.5779 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$141,413.39

CORCEPT THERAPEUTICS INC (CORT)

Sale of 1,225 shares at $115.4395 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$11,564.76

CORCEPT THERAPEUTICS INC (CORT)

Disposition (code F) of 102 shares at $113.38 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$1,261,742.79

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 58,333 shares at $21.63 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code M

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$2,580,674.16

CORCEPT THERAPEUTICS INC (CORT)

Sale of 23,600 shares at $109.3506 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$2,631,348.51

CORCEPT THERAPEUTICS INC (CORT)

Sale of 23,770 shares at $110.7004 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$171,180.76

CORCEPT THERAPEUTICS INC (CORT)

Sale of 1,537 shares at $111.3733 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$109,474.29

CORCEPT THERAPEUTICS INC (CORT)

Sale of 974 shares at $112.3966 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$182,632.23

CORCEPT THERAPEUTICS INC (CORT)

Sale of 1,606 shares at $113.7187 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$10,317.58

CORCEPT THERAPEUTICS INC (CORT)

Disposition (code F) of 91 shares at $113.38 per share.

Reporting Person Robb Gary Charles · Officer Title Chief Business Officer · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382457 · filed 2026-09-03 · View filing →

SEC FORM 4
$11,564.76

CORCEPT THERAPEUTICS INC (CORT)

Disposition (code F) of 102 shares at $113.38 per share.

Reporting Person Mokari Atabak · Officer Title Chief Financial Officer · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382463 · filed 2026-09-03 · View filing →

SEC FORM 4
$13,265.46

CORCEPT THERAPEUTICS INC (CORT)

Disposition (code F) of 117 shares at $113.38 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code F

Traded Sep 2, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382474 · filed 2026-09-03 · View filing →

SEC FORM 4
$14,739.40

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 130 shares at $113.38 per share.

Reporting Person Lyon Joseph Douglas · Officer Title See Remarks · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382450 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 130 shares at $0.00 per share.

Reporting Person Lyon Joseph Douglas · Officer Title See Remarks · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382450 · filed 2026-09-03 · View filing →

SEC FORM 4
$15,646.44

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 138 shares at $113.38 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 138 shares at $0.00 per share.

Reporting Person Vieira Roberto Wandenkolk · Officer Title President, Oncology · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382456 · filed 2026-09-03 · View filing →

SEC FORM 4
$18,594.32

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 164 shares at $113.38 per share.

Reporting Person Robb Gary Charles · Officer Title Chief Business Officer · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382457 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 164 shares at $0 per share.

Reporting Person Robb Gary Charles · Officer Title Chief Business Officer · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382457 · filed 2026-09-03 · View filing →

SEC FORM 4
$15,646.44

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 138 shares at $113.38 per share.

Reporting Person Mokari Atabak · Officer Title Chief Financial Officer · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382463 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 138 shares at $0.00 per share.

Reporting Person Mokari Atabak · Officer Title Chief Financial Officer · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382463 · filed 2026-09-03 · View filing →

SEC FORM 4
$206,750.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 25,000 shares at $8.27 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382474 · filed 2026-09-03 · View filing →

SEC FORM 4
$1,336,458.72

CORCEPT THERAPEUTICS INC (CORT)

Sale of 11,730 shares at $113.9351 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382474 · filed 2026-09-03 · View filing →

SEC FORM 4
$1,260,567.97

CORCEPT THERAPEUTICS INC (CORT)

Sale of 10,989 shares at $114.7118 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382474 · filed 2026-09-03 · View filing →

SEC FORM 4
$263,710.52

CORCEPT THERAPEUTICS INC (CORT)

Sale of 2,281 shares at $115.6118 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382474 · filed 2026-09-03 · View filing →

SEC FORM 4
$17,007.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 150 shares at $113.38 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382474 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 150 shares at $0.00 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382474 · filed 2026-09-03 · View filing →

SEC FORM 4
$18,594.32

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 164 shares at $113.38 per share.

Reporting Person Guyer William · Officer Title Chief Development Officer · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382475 · filed 2026-09-03 · View filing →

SEC FORM 4
$0.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code A) of 164 shares at $0 per share.

Reporting Person Guyer William · Officer Title Chief Development Officer · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001193125-26-382475 · filed 2026-09-03 · View filing →

SEC FORM 4
$404,700.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 30,000 shares at $13.49 per share.

Reporting Person Park Kimberly · Transaction Code M

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001193125-26-374607 · filed 2026-08-28 · View filing →

SEC FORM 4
$404,728.35

CORCEPT THERAPEUTICS INC (CORT)

Disposition (code F) of 3,315 shares at $122.09 per share.

Reporting Person Park Kimberly · Transaction Code F

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001193125-26-374607 · filed 2026-08-28 · View filing →

SEC FORM 4
$3,270,169.36

CORCEPT THERAPEUTICS INC (CORT)

Sale of 26,685 shares at $122.5471 per share.

Reporting Person Park Kimberly · Transaction Code S

Traded Aug 26, 2026 · Disclosed Aug 28, 2026

Source: SEC Form 4 · 0001193125-26-374607 · filed 2026-08-28 · View filing →

SEC FORM 4
$351,339.25

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 30,955 shares at $11.35 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code M

Traded Aug 25, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001193125-26-371388 · filed 2026-08-27 · View filing →

SEC FORM 4
$3,147,354.75

CORCEPT THERAPEUTICS INC (CORT)

Sale of 25,085 shares at $125.4676 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001193125-26-371388 · filed 2026-08-27 · View filing →

SEC FORM 4
$739,965.16

CORCEPT THERAPEUTICS INC (CORT)

Sale of 5,870 shares at $126.0588 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code S

Traded Aug 25, 2026 · Disclosed Aug 27, 2026

Source: SEC Form 4 · 0001193125-26-371388 · filed 2026-08-27 · View filing →

SEC FORM 4
$585,478.45

CORCEPT THERAPEUTICS INC (CORT)

Sale of 4,984 shares at $117.4716 per share.

Reporting Person MAHONEY DAVID L · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001193125-26-359255 · filed 2026-08-20 · View filing →

SEC FORM 4
$10,779,367.28

CORCEPT THERAPEUTICS INC (CORT)

Sale of 91,167 shares at $118.2376 per share.

Reporting Person MAHONEY DAVID L · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001193125-26-359255 · filed 2026-08-20 · View filing →

SEC FORM 4
$838,710.39

CORCEPT THERAPEUTICS INC (CORT)

Sale of 7,055 shares at $118.8817 per share.

Reporting Person MAHONEY DAVID L · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001193125-26-359255 · filed 2026-08-20 · View filing →

SEC FORM 4
$47,855.24

CORCEPT THERAPEUTICS INC (CORT)

Sale of 400 shares at $119.6381 per share.

Reporting Person MAHONEY DAVID L · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 20, 2026

Source: SEC Form 4 · 0001193125-26-359255 · filed 2026-08-20 · View filing →

SEC FORM 4
$1,162,572.00

CORCEPT THERAPEUTICS INC (CORT)

Sale of 10,000 shares at $116.2572 per share.

Reporting Person Robb Gary Charles · Officer Title Chief Business Officer · Transaction Code S

Traded Aug 17, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355560 · filed 2026-08-18 · View filing →

SEC FORM 4
$337,340.93

CORCEPT THERAPEUTICS INC (CORT)

Sale of 3,053 shares at $110.4949 per share.

Reporting Person WILSON JAMES N · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355562 · filed 2026-08-18 · View filing →

SEC FORM 4
$520,213.59

CORCEPT THERAPEUTICS INC (CORT)

Sale of 4,668 shares at $111.4425 per share.

Reporting Person WILSON JAMES N · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355562 · filed 2026-08-18 · View filing →

SEC FORM 4
$256,706.10

CORCEPT THERAPEUTICS INC (CORT)

Sale of 2,279 shares at $112.6398 per share.

Reporting Person WILSON JAMES N · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355562 · filed 2026-08-18 · View filing →

SEC FORM 4
$30,301.28

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 3,664 shares at $8.27 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code M

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355563 · filed 2026-08-18 · View filing →

SEC FORM 4
$419,491.36

CORCEPT THERAPEUTICS INC (CORT)

Sale of 3,664 shares at $114.49 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code S

Traded Aug 14, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001193125-26-355563 · filed 2026-08-18 · View filing →

SEC FORM 4
$352,895.00

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 16,300 shares at $21.65 per share.

Reporting Person Guyer William · Officer Title Chief Development Officer · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346942 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,304,933.12

CORCEPT THERAPEUTICS INC (CORT)

Sale of 11,530 shares at $113.1772 per share.

Reporting Person Guyer William · Officer Title Chief Development Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346942 · filed 2026-08-12 · View filing →

SEC FORM 4
$543,956.97

CORCEPT THERAPEUTICS INC (CORT)

Sale of 4,770 shares at $114.0371 per share.

Reporting Person Guyer William · Officer Title Chief Development Officer · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346942 · filed 2026-08-12 · View filing →

SEC FORM 4
$8,526.37

CORCEPT THERAPEUTICS INC (CORT)

Acquisition (code M) of 1,031 shares at $8.27 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346951 · filed 2026-08-12 · View filing →

SEC FORM 4
$118,068.26

CORCEPT THERAPEUTICS INC (CORT)

Sale of 1,031 shares at $114.5182 per share.

Reporting Person Maduck Sean · Officer Title See Remarks · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001193125-26-346951 · filed 2026-08-12 · View filing →